Teachers Advisors LLC raised its holdings in shares of PetMed Express, Inc. (NASDAQ:PETS) by 5.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 65,173 shares of the company’s stock after acquiring an additional 3,289 shares during the period. Teachers Advisors LLC owned approximately 0.32% of PetMed Express worth $2,646,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also made changes to their positions in PETS. Russell Investments Group Ltd. lifted its stake in PetMed Express by 62.8% during the 1st quarter. Russell Investments Group Ltd. now owns 66,319 shares of the company’s stock valued at $1,335,000 after acquiring an additional 25,579 shares during the period. Bank of New York Mellon Corp lifted its stake in PetMed Express by 2.9% during the 1st quarter. Bank of New York Mellon Corp now owns 382,168 shares of the company’s stock valued at $7,696,000 after acquiring an additional 10,597 shares during the period. Comerica Bank lifted its stake in PetMed Express by 3.9% during the 1st quarter. Comerica Bank now owns 22,619 shares of the company’s stock valued at $526,000 after acquiring an additional 858 shares during the period. Karp Capital Management Corp acquired a new stake in PetMed Express during the 1st quarter valued at approximately $496,000. Finally, Ameriprise Financial Inc. lifted its stake in PetMed Express by 6.1% during the 1st quarter. Ameriprise Financial Inc. now owns 159,220 shares of the company’s stock valued at $3,183,000 after acquiring an additional 9,164 shares during the period. Institutional investors and hedge funds own 81.09% of the company’s stock.
Several analysts have commented on the stock. Zacks Investment Research upgraded shares of PetMed Express from a “sell” rating to a “hold” rating and set a $50.00 price objective for the company in a research note on Friday, October 20th. ValuEngine cut shares of PetMed Express from a “buy” rating to a “hold” rating in a research note on Monday, October 2nd. Credit Suisse Group reiterated an “underperform” rating and issued a $19.00 target price on shares of PetMed Express in a research note on Monday, October 2nd. Sidoti upgraded shares of PetMed Express from a “neutral” rating to a “buy” rating and set a $47.00 target price for the company in a research note on Thursday, August 24th. Finally, BidaskClub cut shares of PetMed Express from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, August 22nd. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $42.00.
In other PetMed Express news, Director Robert C. Schweitzer sold 2,500 shares of the firm’s stock in a transaction on Tuesday, August 1st. The stock was sold at an average price of $49.18, for a total value of $122,950.00. Following the completion of the sale, the director now owns 88,834 shares of the company’s stock, valued at $4,368,856.12. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 4.00% of the stock is currently owned by company insiders.
PetMed Express, Inc. (PETS) opened at 34.92 on Friday. The firm has a market capitalization of $708.60 million, a PE ratio of 26.86 and a beta of 1.03. The company has a 50 day moving average of $35.91 and a 200 day moving average of $36.42. PetMed Express, Inc. has a 1-year low of $18.90 and a 1-year high of $50.90.
PetMed Express (NASDAQ:PETS) last issued its quarterly earnings results on Monday, October 23rd. The company reported $0.43 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.30 by $0.13. PetMed Express had a return on equity of 31.46% and a net margin of 11.58%. The firm had revenue of $66.70 million during the quarter, compared to the consensus estimate of $63.41 million. During the same period last year, the company earned $0.24 earnings per share. The company’s revenue for the quarter was up 9.7% on a year-over-year basis. Analysts forecast that PetMed Express, Inc. will post $1.57 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 17th. Shareholders of record on Monday, November 6th will be issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 2.29%. The ex-dividend date of this dividend is Friday, November 3rd. PetMed Express’s dividend payout ratio (DPR) is currently 53.69%.
WARNING: This piece was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of US & international copyright legislation. The original version of this piece can be read at https://www.dispatchtribunal.com/2017/10/28/petmed-express-inc-pets-stake-lifted-by-teachers-advisors-llc.html.
PetMed Express Company Profile
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related companies with MarketBeat.com's FREE daily email newsletter.